Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 6Terminated 3Withdrawn 2Unknown 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 1Depression 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Anorexia 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Mirtazapine × Clear all
NCT05380479 2022-05-18

Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 2 Unknown
80 enrolled

Anorexia, Cachexia, Neoplasms

NCT02650544 2016-01-08

Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression

Sun Yat-sen University

Phase 2 Unknown
236 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡